3 gennaio 2008 / 12:56 / 10 anni fa

Celgene takeover of Pharmion clears antitrust hurdle

Jan 3 (Reuters) - Celgene Corp (CELG.O) said its proposed $2.9 billion acquisition of Pharmion Corp PHRM.O cleared an antitrust hurdle.

The 30-day waiting period under the Hart-Scott-Rodino Act had expired without the U.S. Federal Trade Commission requesting additional information, the company said in a statement.

The companies expect the transaction to close in April. (Reporting by Sharangdhar Limaye in Bangalore; Editing by Deepak Kannan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below